Shattuck Labs, Inc.
						STTK
					
					
							
								$1.99
								$0.073.65%
								
							
						NASDAQ
					
				Rating
							Reward
									
							Risk
									
							Rating Factors
							Growth Index
									
							Efficiency Index
									
							Solvency Index
									
							Total Return Index
									
							Volatility Index
									
							Dividend Index
									
							Headlines
						
												10/28/2025
												 - 
												MarketBeat
											
										
												10/27/2025
												 - 
												Ticker Report
											
										
												10/26/2025
												 - 
												MarketBeat
											
										
												10/13/2025
												 - 
												TipRanks Financial Blog
											
										
												10/11/2025
												 - 
												Seeking Alpha: Transcripts
											
										
												10/11/2025
												 - 
												SeekingAlpha
											
										
												10/9/2025
												 - 
												MarketBeat
											
										
												10/8/2025
												 - 
												Zacks Investment Research
											
										
												10/3/2025
												 - 
												MarketBeat
											
										
												10/2/2025
												 - 
												MarketBeat
											
										
												10/2/2025
												 - 
												GuruFocus
											
										
												10/2/2025
												 - 
												Globe Newswire
											
										
												9/23/2025
												 - 
												ETF Channel
											
										
												9/19/2025
												 - 
												Ticker Report
											
										
												9/18/2025
												 - 
												TipRanks Financial Blog
											
										
												9/18/2025
												 - 
												The Fly
											
										
												9/18/2025
												 - 
												MarketBeat
											
										
												9/17/2025
												 - 
												24/7 Wall St.
											
										
												9/15/2025
												 - 
												MarketBeat
											
										
												9/15/2025
												 - 
												Zolmax
											
										
												9/12/2025
												 - 
												MarketBeat
											
										
												9/11/2025
												 - 
												Ticker Report
											
										
												9/10/2025
												 - 
												MarketBeat
											
										
												9/10/2025
												 - 
												MarketBeat
											
										Income Statement
						Total Revenue (TTM)
							
						EBITDA (TTM)
							
						EBIT (TTM)
							
						Net Income (TTM)
							
						Balance Sheet
						Total Assets (Q)
							
						Total Debt (Q)
							
						Total Liabilities (Q)
							
						Book Value Per Share (Q)
							
						Cash Flow
						Cash from Operations (TTM)
							
						Cash from Investing (TTM)
							
						Cash from Financing (TTM)
							
						Net Change in Cash (TTM)
							
						Filings
						Filing Date
							Thursday, August 14, 2025
						Period Date
							Monday, June 30, 2025
						Next Filing
							Week of Nov 10 and 14 (est)
						Price History
						Beta
							
						7-Day Total Return
							
						30-Day Total Return
							
						60-Day Total Return
							
						90-Day Total Return
							
						Year to Date Total Return
							
						1-Year Total Return
							
						2-Year Total Return
							
						3-Year Total Return
							
						5-Year Total Return
							
						52-week Low
							
						52-week High
							
						Valuation
						
						Enterprise Value
							
						Price/Sales (TTM)
							
						Price/Book (Q)
							
						Dividends and Shares
						Shares Outstanding
							
						Dividend Per Share (Most Recent)
							--
						Dividend Per Share (TTM)
							--
						Corporate Info
						Website
							
						Phone Number
							512 900 4690
						Address
							
500 West 5th Street 
Austin, TX 78701
						Austin, TX 78701
Country
							
						Year Founded
							
						Business Description
						Sector
							
						
								
									Shattuck Labs, Inc., a biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases. The company’s lead product candidate includes SL-325, a DR3...
									more